Compare ACADIA Pharmaceuticals Inc. (ACAD) vs Ferrari NV (RACE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ACADIA Pharmaceuticals Inc. vs Ferrari NV — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.52 (market cap $5.07B), while Ferrari NV trades at $406 (market cap $71.67B). The key difference: Ferrari NV is far larger — about 14.1× ACADIA Pharmaceuticals Inc.'s market cap, and Ferrari NV pays a 1.04% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | RACE | |
|---|---|---|
Market Cap | $5.07B | $71.67B |
Sector | Health | Consumer Cyclical |
52-Week High | $29.41 | $504.09 |
52-Week Low | $20.06 | $314.63 |
Enterprise Value | $4.19B | $73.60B |
Dividend Yield | — | 1.04% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →About Ferrari NV
Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.
Read more on RACE →
